KDR and neoplasm: Patients with negative (n = 162) or weak (n = 22) VEGFR-2 tumor cell expression levels showed significantly longer overall survival than those displaying a moderate (n = 5) or strong (n = 1) expression of VEGFR-2 in tumor cells.